GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer (Q42501865)

1 November 2017

GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer (English)

1 reference

1 November 2017

1 reference

Tomohiro Miyake

1

1 reference

1 November 2017

Takahiro Nakayama

2

1 reference

1 November 2017

Yasuto Naoi

3

1 reference

1 November 2017

Noriaki Yamamoto

4

1 reference

1 November 2017

Yoko Otani

5

1 reference

1 November 2017

Seung J Kim

6

1 reference

1 November 2017

Kenzo Shimazu

7

1 reference

1 November 2017

Atsushi Shimomura

8

1 reference

1 November 2017

Naomi Maruyama

9

1 reference

1 November 2017

Yasuhiro Tamaki

10

1 reference

1 November 2017

Shinzaburo Noguchi

11

1 reference

1 November 2017

1 March 2012

1 reference

1 November 2017

1 reference

1 November 2017

103

1 reference

1 November 2017

913-920

1 reference

1 November 2017

5

1 reference

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Primary systemic therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Regulation of JNK signaling by GSTp

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Expression of MDR1 and glutatione S transferase-π genes and chemosensitivities in human gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Over-expression of P-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Glutathion S transferase pi indicates chemotherapy resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Association of loss of BRCA1 expression with centrosome aberration in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Prognostic significance of glutathione S-transferase-pi in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Gene expression omnibus: microarray data storage, submission, retrieval, and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02231.X

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

21 January 2018

1 reference

12 December 2020

p53 expression and resistance against paclitaxel in patients with metastatic breast cancer

1 reference

12 December 2020

Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

1 reference

12 December 2020

Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers

1 reference

12 December 2020

Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers

1 reference

12 December 2020

Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer

1 reference

12 December 2020

A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer

1 reference

12 December 2020

Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.

1 reference

12 December 2020

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

12 December 2020

BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02231.X

Identifiers

DOI

1 reference

1 November 2017

1 reference